Merck Sharp and Dohme Corporation v Wyeth LLC (No 3)

JurisdictionAustralia Federal only
JudgeBURLEY J
Judgment Date14 October 2020
Neutral Citation[2020] FCA 1477
CourtFederal Court
Date14 October 2020
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
9 cases
  • Globaltech Corporation Pty Ltd v Reflex Instruments Asia Pacific Pty Ltd
    • Australia
    • Federal Court
    • July 12, 2022
    ...235 CLR 173 Lundbeck A/S v Alphapharm Pty Ltd [2009] FCAFC 70; (2009) 177 FCR 151 Merck Sharp & Dohme Corporation v Wyeth LLC (No 3) [2020] FCA 1477; (2020) 155 IPR 1 Minnesota Mining & Manufacturing Co v Beiersdorf (Australia) Ltd [1980] HCA 9; (1980) 144 CLR 253 Nicaro Holdings Pty Ltd v ......
  • Rakman International Pty Limited v Trafalgar Group Pty Ltd
    • Australia
    • Federal Court
    • April 29, 2022
    ...Liberation Developments Pty Ltd v Lomax Group Pty Ltd [2019] FCA 1180; 144 IPR 413 Merck Sharp & Dohme Corporation v Wyeth LLC (No 3) [2020] FCA 1477; 155 IPR 1477 Moorgate Tobacco Co. Limited v Philip Morris Limited (No 2) (1984) 156 CLR 414 Mylan Health Pty Ltd v Sun Pharma ANZ Pty Ltd [2......
  • ToolGen Incorporated v Fisher (No 2)
    • Australia
    • Federal Court
    • July 14, 2023
    ...Inc [1993] RPC 7 Merck & Co Inc v Arrow Pharmaceuticals Ltd (2006) 154 FCR 31 Merck Sharp & Dohme Corporation v Wyeth LLC (No 3) (2020) 155 IPR 1 Minnesota Mining and Manufacturing Company v Beiersdorf (Australia) Limited (1980) 144 CLR 253 Nicaro Holdings Pty Ltd v Martin Engineering Co (1......
  • Cytec Industries Inc. v Nalco Company
    • Australia
    • Federal Court
    • August 19, 2021
    ...8; 207 CLR 1 Les Laboratoires Servier v Apotex Pty Ltd [2016] FCAFC 27; 247 FCR 61 Merck Sharp & Dohme Corporation v Wyeth LLC (No 3) [2020] FCA 1477; 155 IPR 1 Mont Adventure Equipment Pty Ltd v Phoenix Leisure Group Pty Ltd [2009] FCAFC 84; 176 FCR 575 Novartis AG v Johns & Johnson Medica......
  • Request a trial to view additional results
6 firm's commentaries
  • The 2023 IP year in review, and predictions for 2024
    • Australia
    • Mondaq Australia
    • February 6, 2024
    ...9 Jusand Nominees Pty Ltd v Rattlejack Innovations Pty Ltd [2023] FCAFC 178 10 Merck Sharp & Dohme Corporation v Wyeth LLC (No 3) [2020] FCA 1477 The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific...
  • The practice of incorporation by reference in patent specifications
    • Australia
    • Mondaq Australia
    • August 24, 2022
    ...addressee would regard the document incorporated by reference into the patent. In Merck Sharp & Dohme Corporation v Wyeth LLC (No 3) (2020) 155 IPR 1, Wyeth submitted (at 891) that prior art document "Jones 2005" was not to be understood as being incorporated by reference in the specificati......
  • Additional trial article - Pearce IP confirms higher bar for sufficiency and support in Australian patent law
    • Australia
    • Mondaq Australia
    • September 21, 2021
    ...requirement post-Raising the Bar, Burley J unsurprisingly endorsed his own statement of the law in Merck Sharp & Dohme v Wyeth (No 3) [2020] FCA 1477, including that the technical contribution to the art of the specification must justify the breadth of the monopoly claimed. Based on the Jud......
  • Additional trial article - Pearce IP confirms higher bar for sufficiency and support in Australian patent law
    • Australia
    • Mondaq Australia
    • September 21, 2021
    ...requirement post-Raising the Bar, Burley J unsurprisingly endorsed his own statement of the law in Merck Sharp & Dohme v Wyeth (No 3) [2020] FCA 1477, including that the technical contribution to the art of the specification must justify the breadth of the monopoly claimed. Based on the Jud......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT